Position in KRYS
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$33,601,569
+$9,991,121 QoQ
Shares Held
90,407
-1.1% QoQ
Ownership
0.305%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#42
of 416 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Handelsbanken Fonder AB holds $686,434,691 across 88 Biotechnology names. KRYS ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
218,292 | $108,432,185 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
631,899 | $49,458,734 | |
| 3 | ARGX |
Argenx SE
|
52,653 | $48,849,873 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
212,275 | $39,754,862 | |
| 5 | CYTK |
Cytokinetics Inc
|
405,000 | $34,501,950 | |
| 6 | KRYS |
Krystal Biotech, Inc.
This page
|
90,407 | $33,601,569 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,328 | $32,628,601 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
107,255 | $32,286,972 |
All Filings in KRYS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,601,569 | 90,407 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $23,610,448 | 91,400 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $26,083,932 | 105,800 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $11,792,204 | 66,800 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,182,328 | 66,800 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,396,290 | 74,300 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $13,363,098 | 85,300 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $17,238,241 | 94,700 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $19,557,660 | 106,500 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $18,718,236 | 105,200 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $15,284,192 | 123,200 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $13,084,800 | 112,800 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $12,585,280 | 107,200 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $8,422,312 | 105,200 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $8,333,944 | 105,200 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $7,311,530 | 104,900 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $7,413,014 | 112,900 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $7,319,400 | 110,000 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $6,295,500 | 90,000 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,698,900 | 90,000 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $6,120,000 | 90,000 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $6,933,600 | 90,000 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $5,400,000 | 90,000 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,874,500 | 90,000 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,727,800 | 90,000 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||